Motoi Y

References (3)

Title : Switching from Oral Cholinesterase Inhibitors to a Transdermal Donepezil Patch Attenuated Gastrointestinal Symptoms and Allowed Treatment Continuation in Three Patients with Alzheimer's Disease in Clinical Settings - Motoi_2026_Brain.Sci_16_
Author(s) : Motoi Y , Sanjo N
Ref : Brain Sci , 16 : , 2026
Abstract :
PubMedSearch : Motoi_2026_Brain.Sci_16_
PubMedID: 41594819

Title : Involvement of the Septo-Hippocampal Cholinergic Pathway in Association with Septal Acetylcholinesterase Upregulation in a Mouse Model of Tauopathy - Hara_2017_Curr.Alzheimer.Res_14_94
Author(s) : Hara Y , Motoi Y , Hikishima K , Mizuma H , Onoe H , Matsumoto SE , Elahi M , Okano H , Aoki S , Hattori N
Ref : Curr Alzheimer Res , 14 :94 , 2017
Abstract :
PubMedSearch : Hara_2017_Curr.Alzheimer.Res_14_94
PubMedID: 27335039

Title : Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study - Ishikawa_2014_Psychogeriatrics_14_93
Author(s) : Ishikawa K , Motoi Y , Mizuno Y , Kubo S , Hattori N
Ref : Psychogeriatrics , 14 :93 , 2014
Abstract :
PubMedSearch : Ishikawa_2014_Psychogeriatrics_14_93
PubMedID: 24661498